3D1015
/ 3DMed
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
August 28, 2025
SUCCESSFULLY ADMINISTERS FIRST DOSE IN HUMAN FOR NOVEL RADIOACTIVE DRUG CONJUGATE 3D1015
(HKEXnews)
- "The study aims to evaluate the safety and preliminary efficacy of 3D1015 in patients with PSMA-positive metastatic castration-resistant prostate cancer (mCRPC)."
Trial status • Castration-Resistant Prostate Cancer
1 to 1
Of
1
Go to page
1